Augmenting solute clearance in peritoneal dialysis. 1998

R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
Department of Medicine, University of Amsterdam, The Netherlands.

BACKGROUND The removal of low molecular weight solutes by peritoneal dialysis is less than by hemodialysis. The targets for Kt/Vurea and creatinine clearance formulated in the Dialysis Outcome Quality Initiative are unlikely to be achieved in a substantial portion of peritoneal dialysis patients. Possibilities to increase small solute clearances have therefore been subject to many investigations. METHODS A review of the literature and of recent new data on determinants of solute removal, such as residual renal function, the role of drained dialysate volume and manipulation of the diffusive capacity of the peritoneum are presented. RESULTS The contribution of residual GFR is more important for the clearance of creatinine than for Kt/Vurea. It is even more important for the removal of organic acids that are removed from the body by tubular secretion. High dosages of furosemide increase the urinary volume and the fractional Na+ excretion, but have no effect on the magnitude of residual GFR, renal creatinine clearance, renal urea clearance, and peritoneal transport characteristics. The drained dialysate volume per day is the main determinant of the peritoneal removal of urea. Its effect decreases the higher the molecular weight of a solute. It can be augmented by using large instillation volumes, by the application of more exchanges, and by increasing peritoneal ultrafiltration. A large exchange volume is especially effective in patients with an average transport state, but in those with high solute transport rates, Kt/Vurea is especially influenced by the number of exchanges. Possibilities to increase ultrafiltration are discussed. The diffusive capacity of the peritoneum can be augmented by using low dosages of intraperitoneally administered nitroprusside. This increases solute transport most markedly when it is applied in combination with icodextrin as osmotic agent. CONCLUSIONS Small solutes clearances cannot be increased by furosemide. Increasing the instilled volume of dialysis fluid and the number of exchanges both affect solute clearance. Studies are necessary on long-term effects of manipulation of the peritoneal membrane with nitroprusside.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 2008, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 2009, Contributions to nephrology,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
February 2014, Clinical journal of the American Society of Nephrology : CJASN,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
April 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
April 2020, Clinical journal of the American Society of Nephrology : CJASN,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
January 2008, Blood purification,
R T Krediet, and C E Douma, and R W van Olden, and M M Ho-dac-Pannekeet, and D G Struijk
March 2016, Artificial organs,
Copied contents to your clipboard!